Thank you for your interest in our fellowship program. The Hofstra North Shore-LIJ School of Medicine Program [Rheumatology] currently offers two positions each year to board eligible internists who have completed three years of training in Internal Medicine in an accredited US or Canadian training program. The two-year subspecialty program provides supervised training at a level that allows the fellow to acquire the expertise and competency of a specialist in Rheumatology, according to the requirements set forth by the Accreditation Council of Graduate Medical Education. We offer a closely mentored experience in the diagnosis and management of patients with rheumatic diseases in both inpatient and ambulatory settings. Fellows are required to participate in scholarly activities involving teaching and basic and clinical research. A postgraduate PhD or MPH program can be linked with the fellowship program for those fellows interested in pursuing a career in academic medicine.

Program Description

The Rheumatology fellowship program provides comprehensive training in clinical and investigative rheumatology and related basic science to prepare rheumatologists for careers in clinical practice and/or investigative rheumatology. The fellowship program is fully integrated into the activities of the Division of Rheumatology at Hofstra North Shore -LIJ School of Medicine and the Centers for Autoimmune and Musculoskeletal Diseases and Genetics at the Feinstein Institute for Medical Research.  It includes at least 12 months of clinical training and 9-12 months of a focused research experience. The clinical training occurs in two tertiary care institutions, Long Island Jewish Medical Center (LIJ) and North Shore University Hospital (NSUH). The nearly 1,800 in-patient beds and the two active emergency departments in our hospitals provide the trainee with exposure to large numbers of acutely ill patients. Fellows also participate in continuity care clinic experiences in both institutions as well as in the faculty outpatient practices for a total of two-three half-days per week throughout the length of the training period. The program includes training in the performance of joint aspirates and joint and soft tissue injections, the infusion of biologic agents, the performance and interpretation of joint ultrasound, and participation in clinical trials. The presence of accredited subspecialty programs in other disciplines on campus fosters peer interactions that create an outstanding learning environment for rheumatology fellows. Elective rotations in Pediatric Rheumatology, Rehabilitation Medicine, Sports Medicine, Orthopedics, Skeletal Radiology, Neurology, Metabolic Bone and Nuclear Medicine enable the trainee to develop skills in allied areas. There is a weekly conference schedule which includes clinical, core and multidisciplinary conferences, case presentations, radiology, journal clubs and a roster of invited speakers. Opportunities for teaching residents and medical students and for continuing medical education at regional and national conferences and workshops are plentiful.

In their second year, fellows choose an area of clinical or basic science research and pursue it actively under the guidance of a faculty member. The Autoimmune and Musculoskeletal Diseases Center and the Boas Center for Genetics at the Feinstein Institute for Medical Research provide opportunities to participate in investigator-initiated clinical trials and in basic and translational research and to take rigorous courses in investigative medicine and in statistics. A 3 year post-MD PhD training program at the Feinstein Institute is available through the Elmezzi program.  A 2 year MPH program is available through Hofstra University.

For additional fellowship program information please contact :
Beeneka Prashad, Fellowship Liaison
Email: bprashad@nshs.edu

Key Faculty

Richard Furie, MD

Chief, Division of Rheumatology and Allergy-Clinical Immunology
Professor of Medicine, Hofstra North Shore – LIJ School of Medicine

Dr. Richard Furie’s interests lie in the management of patients with lupus and Antiphospholipid Antibody Syndrome.   He is particularly active in clinical research aimed at advancing new therapies for rheumatic disease patients.  He directs the Division’s clinical research program, the Program in Novel Therapeutics.  He has also been quite active with the American College of Rheumatology’s educational committees.

ABIM status:  Board Certified in Internal Medicine and Rheumatology.

Cynthia Aranow, MD

Associate Investigator, Center for Autoimmune and Musculoskeletal Disorders, The Feinstein Institute for Medical research
Associate Professor of Molecular Medicine and Medicine, Hofstra North Shore-LIJ School of Medicine

Dr. Cynthia Aranow is a rheumatologist specializing in lupus and rheumatoid arthritis. She is a co-director of the Clinical Trials Unitof the Center for Autoimmune Disease.  The Center for Autoimmune Disease focuses its research efforts on Systemic Lupus Erythematosus and rheumatoid arthritis in addition to other autoimmune diseases. 

ABIM status:  Board Certified in Internal Medicine and Rheumatology.

Maria-Louise Barilla-LaBarca, MD

Director, Center for Performing Arts Medicine
Director, Gout and Crystalline Arthritis Center
Director, Musculoskeletal Ultrasound Program
Medical Director, Clinical Skills Center for Hofstra North Shore - LIJ School of Medicine

Dr. Barilla-LaBarca oversees several centers of excellence within the clinical division including the Gout and Crystalline Arthritis Center, the Program in Musculoskeletal Ultrasound and the Center for Performance Art Medicine (CPAM).  Additionally she is Medical Director for the Clinical Skills Center for the Hofstra North Shore LIJ School of Medicine. She mentors individuals across training levels in multiple capacities including patient care and ultrasound instruction.

ABIM status: Board Certified in Internal Medicine and Rheumatology.

Anne Davidson, MBBS

Fellowship Program Director, Division of Rheumatology
Investigator, Feinstein Institute for Medical Research
Professor of Molecular Medicine, Hofstra North Shore – LIJ School of Medicine

Dr. Davidson is interested in immune tolerance and renal inflammation in SLE. Her research laboratory is at the Feinstein Institute.

ABIM status:  Board Certified in Rheumatology.

Betty Diamond, MD

Investigator & Head, Center for Autoimmune and Musculoskeletal Diseases, The Feinstein Institute for Medical Research
Professor of Molecular Medicine and Medicine, Hofstra North Shore-LIJ School of Medicine

Dr. Diamond’s laboratory studies DNA-reactive B cells in the autoimmune disease systemic lupus erythematosus. A former president of the American Association of Immunology, Dr. Diamond has also served on the board of directors of the American College of Rheumatology and the Scientific Council of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Dr. Diamond is a fellow of the American Association for the Advancement of Science (AAAS) and a member of the Institute of Medicine. Her research laboratory is at the Feinstein Institute.

ABIM status: Board certified in Internal Medicine.

Diane Horowitz, MD

Assistant Professor, Hofstra North Shore – LIJ School of Medicine
Director, The Arthritis Center 
Director, Continuing Medical Education in Rheumatology

Dr. Diane Horowitz focuses her interests on patients with various types of arthritis.  She is expanding the Division’s arthritis programs as well as developing community outreach programs.  She also directs the Division’s program in continuing medical education.  Dr. Horowitz is responsible for 33% of the inpatient teaching and 50% of the outpatient clinic at LIJ.

ABIM status:  Board Certified in Internal Medicine and Rheumatology.

Meggan Mackay, MD, MS 

Assistant Investigator, Autoimmune & Musculoskeletal Disorders, The Feinstein Institute for Medical Research
Associate Professor, Molecular Medicine and Medicine, Hofstra North Shore-LIJ School of Medicine

Dr. Meggan Mackay is a co-director of the Clinical Trials Unit in the Center for Autoimmune Disease. The Center for Autoimmune Disease focuses its research efforts on Systemic Lupus Erythematosus and rheumatoid arthritis in addition to other autoimmune diseases. Prior to her arrival at the Feinstein Institute, Dr. Mackay had been on the faculty at Columbia University Medical Center and the Albert Einstein College of Medicine where she was the Associate Director of Medicine at Jacobi Medical Center.

Galina Marder, MD 

Director, The Center for Vasculitis and Inflammatory Muscle Disease

Dr. Marder directly oversees fellow inpatient performed at north Shore University Hospital LIJ Medical Center and outpatient experiences at LIJ rheumatology clinic. She has served as a mentor for previous fellows' research endeavors.

ABIM status: Board Certified in Internal Medicine and Rheumatology.

Julie Schwartzman-Morris, MD

Associate Professor, Hofstra North Shore-LIJ School of Medicine
Director, Psoriatic Arthritis and Spondyloarthropathy Program
Director, House Staff and Medical School Education

Dr. Julie Schwartzman-Morris’s career interests include Medical Education at the student and resident level, along with patient care in the areas of Psoriatic Arthritis, Rheumatoid Arthritis, Lupus, Osteoporosis, and Scleroderma.  She is the director of the Psoriatic Arthritis and Spondyloarthropathy program and a key clinical faculty member of the North Shore Spine Center.

Dr. Schwartzman-Morris directly oversees fellow inpatient consults performed at North Shore University Hospital, LIJ Medical Center, and outpatient experiences at the North Shore Rheumatology clinic.

She has served as a mentor for housestaff research endeavors and is responsible for the Rheumatology Elective curriculum and schedule for students and housestaff, as well. Prior to her arrival at the North Shore Health System, she had been faculty at Albert Einstein College of Medicine and was the Rheumatology Fellowship Director at Montefiore Medical Center.

Recent Publications

  1. Furie R, Nicholls K, Cheng TT, et al. Efficacy and safety of abatacept in lupus nephritis: a twelve-month, randomized, double-blind study. Arthritis Rheumatol 2014;66:379-89.
  2. Zou YR, Diamond B. Fate determination of mature autoreactive B cells. Adv Immunol 2013;118:1-36.
  3. Mosak J, Furie R. Breaking the ice in systemic lupus erythematosus: belimumab, a promising new therapy. Lupus 2013;22:361-71.
  4. Kim SJ, Gregersen PK, Diamond B. Regulation of dendritic cell activation by microRNA let-7c and BLIMP1. J Clin Invest 2013;123:823-33.
  5. Franchin G, Son M, Kim SJ, Ben-Zvi I, Zhang J, Diamond B. Anti-DNA antibodies cross-react with C1q. J Autoimmun 2013;44:34-9.
  6. Diamond B, Honig G, Mader S, Brimberg L, Volpe BT. Brain-reactive antibodies and disease. Annu Rev Immunol 2013;31:345-85.
  7. Bethunaickan R, Berthier CC, Zhang W, Kretzler M, Davidson A. Comparative transcriptional profiling of 3 murine models of SLE nephritis reveals both unique and shared regulatory networks. PLoS One 2013;8:e77489.
  8. Barilla-Labarca ML, Toder K, Furie R. Targeting the complement system in systemic lupus erythematosus and other diseases. Clin Immunol 2013;148:313-21.
  9. Son M, Santiago-Schwarz F, Al-Abed Y, Diamond B. C1q limits dendritic cell differentiation and activation by engaging LAIR-1. Proc Natl Acad Sci U S A 2012;109:E3160-7.
  10. Simpfendorfer KR, Olsson LM, Manjarrez Orduno N, et al. The autoimmunity-associated BLK haplotype exhibits cis-regulatory effects on mRNA and protein expression that are prominently observed in B cells early in development. Hum Mol Genet 2012;21:3918-25.
  11. Mosak J, Furie R. Comparative safety of therapies in systemic lupus erythematosus. Rheum Dis Clin North Am 2012;38:795-807.
  12. Moisini I, Huang W, Bethunaickan R, et al. The Yaa locus and IFN-alpha fine-tune germinal center B cell selection in murine systemic lupus erythematosus. J Immunol 2012;189:4305-12.
  13. Manjarrez-Orduno N, Marasco E, Chung SA, et al. CSK regulatory polymorphism is associated with systemic lupus erythematosus and influences B-cell signaling and activation. Nat Genet 2012;44:1227-30.
  14. Liu Z, Davidson A. Taming lupus-a new understanding of pathogenesis is leading to clinical advances. Nat Med 2012;18:871-82.
  15. Horowitz DL, Furie R. Belimumab is approved by the FDA: what more do we need to know to optimize decision making? Curr Rheumatol Rep 2012;14:318-23.
  16. Davidson A. The rationale for BAFF inhibition in systemic lupus erythematosus. Curr Rheumatol Rep 2012;14:295-302.
  17. Bethunaickan R, Sahu R, Liu Z, et al. Anti-tumor necrosis factor alpha treatment of interferon-alpha-induced murine lupus nephritis reduces the renal macrophage response but does not alter glomerular immune complex formation. Arthritis Rheum 2012;64:3399-408.
  18. Mackay M, Bussa MP, Aranow C, et al. Differences in regional brain activation patterns assessed by functional magnetic resonance imaging in patients with systemic lupus erythematosus stratified by disease duration. Mol Med 2011;17:1349-56.
  19. Katzap E, Barilla-LaBarca ML, Marder G. Antisynthetase syndrome. Curr Rheumatol Rep 2011;13:175-81.
  20. Rubinstein T, Pitashny M, Levine B, et al. Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis. Rheumatology (Oxford) 2010;49:960-71.
  21. Jacobi AM, Huang W, Wang T, et al. Effect of long-term belimumab treatment on B cells in systemic lupus erythematosus: extension of a phase II, double-blind, placebo-controlled, dose-ranging study. Arthritis Rheum 2010;62:201-10.
  22. Davidson A, Aranow C. Lupus nephritis: lessons from murine models. Nat Rev Rheumatol 2010;6:13-20.
  23. Aranow C, Diamond B, Mackay M. Glutamate receptor biology and its clinical significance in neuropsychiatric systemic lupus erythematosus. Rheum Dis Clin North Am 2010;36:187-201, x-xi.
  24. Barilla-Labarca ML, Tsang JC, Goldsmith M, Furie R. Design, implementation, and outcome of a hands-on arthrocentesis workshop. J Clin Rheumatol 2009;15:275-9.

Additional Information

2015-2016 Fellows

Richard Adamski  2015-2017
Erik Anderson 2015-2017
Melinda Collins 2014-2016
Asaf Klein 2014-2016

Life in the Area

Located in a safe and pleasant locale, North Shore-LIJ Health System is at the crossroads between urban and rural environments. We are in proximity to excellent shopping and diverse dining experiences. Whereas most people own cars, trains and buses permit travel around Long Island but are particularly useful for getting to Manhattan.

What We Do for Fun

We work! With Manhattan just 20 miles to the west and a mere 30 minutes by train, the excitement of Broadway is not far away. Head the other way, and you will find yourself in the vineyards and pastoral settings of eastern Long Island. Head south to the endless beaches on the Atlantic Ocean, whereas just a couple miles north of the hospital are calm bays extending off of the Long Island Sound. Whether you like museums, theatre, golf, cycling, or boating, Long Island has it all. And, if you want to travel three major international airports and train stations are nearby.